Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 11:50 am Purchase | 2024-09-30 | 13G | Avadel Pharmaceuticals plc AVDL | JANUS HENDERSON GROUP PLC JHG | 13,326,887 13.800% | 13,326,887 (New Position) | Filing History |
| 2024-11-14 06:10 am Sale | 2024-09-30 | 13G | Avadel Pharmaceuticals plc AVDL | RTW Investments, LP | 0 0.000% | -9,196,186 (Position Closed) | Filing History |
| 2024-11-13 5:58 pm Sale | 2024-09-30 | 13G | Avadel Pharmaceuticals plc AVDL | Polar Capital Holdings Plc | 4,803,899 4.990% | -1,947,883 (-28.85%) | Filing History |
| 2024-11-13 5:00 pm Sale | 2024-09-30 | 13G | Avadel Pharmaceuticals plc AVDL | COWEN AND COMPANY LLC | 0 0.000% | -3,732,778 (Position Closed) | Filing History |
| 2024-11-08 2:17 pm Unchanged | 2024-09-30 | 13G | Avadel Pharmaceuticals plc AVDL | BlackRock Inc. BLK | 5,257,004 5.500% | 0 (Unchanged) | Filing |
| 2024-10-24 2:02 pm Purchase | 2024-09-30 | 13G | Avadel Pharmaceuticals plc AVDL | BlackRock Inc. BLK | 5,257,004 5.500% | 5,257,004 (New Position) | Filing |
| 2024-02-14 07:11 am Purchase | 2023-12-31 | 13G | Avadel Pharmaceuticals plc AVDL | RTW Investments, LP | 9,196,186 9.990% | 3,454,247 (+60.16%) | Filing History |
| 2024-02-13 5:54 pm Purchase | 2023-12-31 | 13G | Avadel Pharmaceuticals plc AVDL | JANUS HENDERSON GROUP PLC JHG | 11,125,330 12.400% | 1,681,688 (+17.81%) | Filing History |
| 2024-02-13 4:39 pm Purchase | 2023-12-31 | 13G | Avadel Pharmaceuticals plc AVDL | GENDELL JEFFREY L | 5,685,350 6.330% | 494,745 (+9.53%) | Filing History |
| 2024-02-13 09:40 am Purchase | 2023-12-31 | 13G | Avadel Pharmaceuticals plc AVDL | Polar Capital Holdings Plc | 6,751,782 7.510% | 3,957,109 (+141.59%) | Filing History |
| 2024-02-12 08:20 am Purchase | 2024-02-12 | 13G | Avadel Pharmaceuticals plc AVDL | KOTLER KEVIN | 3,716,242 4.100% | 594,142 (+19.03%) | Filing History |
| 2023-08-10 3:25 pm Purchase | 2023-07-31 | 13G | Avadel Pharmaceuticals plc AVDL | JANUS HENDERSON GROUP PLC JHG | 9,443,642 12.300% | 9,443,642 (New Position) | Filing History |
| 2023-03-09 4:13 pm Purchase | 2023-02-14 | 13G | Avadel Pharmaceuticals plc AVDL | KOTLER KEVIN | 3,122,100 5.100% | 265,110 (+9.28%) | Filing History |
| 2023-02-14 4:05 pm Purchase | 2022-12-31 | 13G | Avadel Pharmaceuticals plc AVDL | GENDELL JEFFREY L | 5,190,605 8.400% | 1,015,623 (+24.33%) | Filing History |
| 2023-02-14 10:01 am Sale | 2022-12-31 | 13G | Avadel Pharmaceuticals plc AVDL | RTW Investments, LP | 5,741,939 9.300% | -68,201 (-1.17%) | Filing History |
| 2023-02-13 5:42 pm Sale | 2022-12-31 | 13G | Avadel Pharmaceuticals plc AVDL | Vivo Opportunity LLC | 2,251,663 3.600% | -149,613 (-6.23%) | Filing History |
| 2023-02-13 4:58 pm Sale | 2022-12-31 | 13G | Avadel Pharmaceuticals plc AVDL | KOTLER KEVIN | 2,856,990 4.600% | -583,222 (-16.95%) | Filing History |
| 2022-06-06 4:57 pm Purchase | 2022-05-26 | 13G | Avadel Pharmaceuticals plc AVDL | KOTLER KEVIN | 3,440,212 5.800% | 3,440,212 (New Position) | Filing History |
| 2022-06-03 4:10 pm Purchase | 2022-05-27 | 13G | Avadel Pharmaceuticals plc AVDL | GENDELL JEFFREY L | 4,174,982 7.070% | 4,174,982 (New Position) | Filing History |
| 2022-02-14 10:40 am Sale | 2021-12-31 | 13G | Avadel Pharmaceuticals plc AVDL | Polar Capital Holdings Plc | 2,794,673 4.800% | -233,032 (-7.70%) | Filing History |